Virbac stock eases as investors await a new catalyst

Published on 09/16/2026 at 21:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Virbac stock traded at EUR 312.00 with a 0.95 percent daily drop on September 16, 2026. The company posted EUR 1.20 billion in 2025 revenue and EUR 147.6 million in EBITDA.

Schwarzweißes Reportagefoto eines Veterinärlabors mit Forschern bei der Arbeit — Dokumentarische Schwarzweiß-Reportage über Virbac S.A., Aktie FR0000031577, zeigt ein modernes Labor der Tiergesundheitsbranche, Illustration mit AI erstellt.

Virbac stock (FR0000031577) traded at EUR 312.00 on September 16, 2026, after a 0.95 percent daily drop, with a market capitalization of EUR 3.05 billion. The stock also sat on a 52-week range that framed the move, and the session reference in the market snapshot matched the last completed trading day.

Results still set the tone

Virbac reported EUR 1.20 billion in 2025 revenue and EUR 147.6 million in EBITDA, according to its 2025 results context that remains the latest period visible in the search set. That puts the EBITDA margin at about 12.3 percent, based on the two reported figures.

The same 2025 base is still the key operating anchor for investors because the company also showed EUR 98.2 million in net profit, versus EUR 84.2 million a year earlier. That is a gain of EUR 14.0 million, or 16.6 percent.

What matters now

On the price side, the current quote of EUR 312.00 leaves the shares close to the mid-range of the 52-week band captured in the market snapshot, while the 0.95 percent decline points to mild pressure rather than a sharp move. For investors, the combination of a EUR 3.05 billion market value and double-digit profitability is the main read-through.

Virbac also appeared in Zonebourse's earnings agenda for September 17, 2026, which keeps the stock on the watch list around the next reporting calendar date. That calendar cue matters because the latest visible operating figures are from 2025, so the next update is the next possible catalyst.

Stock level today

Virbac stock stood at EUR 312.00 on September 16, 2026, with a market capitalization of EUR 3.05 billion. The latest quoted session showed a 0.95 percent drop.